...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers
【24h】

Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers

机译:结直肠癌腹膜转移时可见性心绞痛角淋巴结的预后意义

获取原文
获取原文并翻译 | 示例

摘要

Background Visible cardiophrenic angle lymph nodes (CPALN) (enlarged or not), detected on CT scan are correlated with the presence of peritoneal metastases (PM), and contribute to the diagnosis of PM in colorectal cancer patients. Objective To study whether visible CPALN exert a prognostic impact on survival after complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CCRS + HIPEC) treating PM. Patients and methods From 1999 to 2010, 114 patients with colorectal cancer and PM were treated with CCRS + HIPEC. CPALN were depicted in 64% of cases. The impact of visible CPALN on survival was investigated retrospectively. Results The mean peritoneal cancer index (PCI) score was 9.2, 21% of the patients had presented with associated liver metastases, and 71% of the women with ovarian metastases. Median follow-up was 3.9 years. Visible CPALN had no impact on OS nor on DFS, unlike the PCI score which was unequivocably the most potent prognostic factor in the multivariate analysis. Conclusion Although some arguments might suggest that CPALN are malignant, paradoxically, we found that visible CPALN did not exert a positive nor a negative impact on survival after CCRS + HIPEC. Synopsis Visible cardiophrenic angle lymph nodes (CPALN) on CT-scan are strongly associated with the presence of peritoneal metastases. But this study demonstrates that the presence of CPALN has no prognostic impact after optimal cytoreductive surgery plus HIPEC.
机译:背景技术在CT扫描中检测到的可见的心肾角淋巴结(CPALN)(肿大与否)与腹膜转移瘤(PM)的存在相关,并有助于大肠癌患者的PM诊断。目的研究可见的CPALN是否对完全性细胞减灭术联合腹膜热化疗(CCRS + HIPEC)治疗PM后生存率产生影响。患者和方法从1999年至2010年,对114例结直肠癌和PM患者进行了CCRS + HIPEC治疗。在64%的病例中描述了CPALN。回顾性研究了可见CPALN对生存的影响。结果平均腹膜癌指数(PCI)评分为9.2,其中21%的患者有相关肝转移,而71%的女性有卵巢转移。中位随访时间为3.9年。可见的CPALN对OS和DFS均无影响,而PCI评分无疑是多变量分析中最有力的预后因素。结论尽管有些争论可能暗示CPALN是恶性的,但自相矛盾的是,我们发现可见的CPALN对CCRS + HIPEC后的存活率没有正面或负面的影响。概要CT扫描上可见的心源性角淋巴结(CPALN)与腹膜转移的存在密切相关。但是这项研究表明,CPALN的存在对最佳的细胞减灭术加HIPEC后没有预后影响。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号